Imidazopyridines
Sigma Aldrich 1-(Boc-amino)-3-butene
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
Medchemexpress LLC HY-100414 1mg Medchemexpress, Soraprazan CAS:261944-46-1 Purity:>98%
Medchemexpress, HY-100414 1mg Soraprazan CAS:261944-46-1 Soraprazan (BYK61359) is a reversible, and fast-acting inhibitor of gastric H + /K + ATPase . Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC CXCR7 modulator 1 10mg | 2231812-31-8 | 10MG
CXCR7 modulator 1 (compound 25) is a potent and orally bioavailable peptoid hybrid CXCR7 modulator with a Ki of 9 nM[1
Medchemexpress LLC PDE2A-IN-3 | 1426833-08-0 | 295.73 | 100 MG
PDE2A-IN-3 is a selective phosphodiesterase 2A (PDE2A) inhibitor with IC50s of 69 nM and 1762 nM for PDE2A and PDE10, respectively. It can be used for the study of neurological and psychiatric disorders.
- Selective phosphodiesterase 2A (PDE2A) inhibitor
- IC50 of 69 nM for PDE2A
- IC50 of 1762 nM for PDE10
- Suitable for studying neurological and psychiatric disorders
![Medchemexpress LLC 4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluorom | 939375-07-2 | 99.9% | 420.39 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000393984.png-250.jpg)
Medchemexpress LLC 4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluorom | 939375-07-2 | 99.9% | 420.39 | 100 MG
DGAT1-IN-3 is a potent, selective, and orally bioavailable inhibitor of DGAT-1. It can be used for research on obesity, dyslipidemia, and metabolic syndrome.
- Potent, selective, and orally bioavailable inhibitor of DGAT-1.
- Inhibits human DGAT-1 with an IC50 of 38 nM.
- Inhibits rat DGAT-1 with an IC50 of 120 nM.
- Supports research into obesity.
- Supports research into dyslipidemia.
- Supports research into metabolic syndrome.
- Reduces cumulative body weight gain in DIO rats.
- Reduces weight gain and plasma triglycerides.
- Improves lipid profiles.
Medchemexpress LLC CXCR7 antagonist-1 | 1613021-99-0 | 99.9% | C21H19FN6O | 10MG
CXCR7 antagonist-1 is a research-grade small-molecule antagonist of the chemokine receptor CXCR7 (CAS 1613021-99-0). It inhibits binding of CXCL12/SDF-1 and CXCL11/I-TAC to CXCR7 and is supplied with high purity for in vitro and in vivo exploratory studies of tumor cell proliferation, migration, and inflammatory signaling.
- High purity suitable for biochemical and cellular assays.
- Known mechanism: blocks CXCL12 and CXCL11 binding to CXCR7.
- Available in multiple packaging sizes and solution formats.
- Recommended storage and handling information provided.
- Supplied for research use only.
Medchemexpress LLC IL-17A modulator-2 | 2748749-47-3 | 98.4% | 577.63 | C33H31N5O5 | 5 MG
IL-17A modulator-2 is a small-molecule research compound that inhibits the biological activity of interleukin-17A. Reported from patent WO2021239743 (example 27), it is intended for use in preclinical studies investigating immune-related, autoimmune, cancer, and neurodegenerative disorders.
- Inhibits interleukin-17A with a reported pIC50 of 8.3.
- High purity suitable for research applications (≈98.4%).
- Molecular weight 577.63; formula C33H31N5O5.
- Available in small quantities appropriate for in vitro assays.
- Reportedly derived from a patent example, supporting reproducible synthesis.
- Intended for research use only; not for human therapeutic use.
Medchemexpress LLC HY-12425 5mg Medchemexpress, DGAT1-IN-1 CAS:1449779-49-0 Purity:>98%
Medchemexpress, HY-12425 5mg DGAT1-IN-1 CAS:1449779-49-0 Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Cxcr7 modulator 1 | 2231812-31-8 | 99.5% | 914.07 | C48H57F2N7O7S | 50 MG
CXCR7 modulator 1 is a potent, orally bioavailable peptoid-hybrid modulator of the chemokine receptor CXCR7 with an in vitro Ki of 9 nM. It is supplied for preclinical biochemical and pharmacological research into CXCR7 signaling and ligand-receptor interactions.
- Potent CXCR7 affinity (Ki = 9 nM)
- Orally bioavailable chemical scaffold suitable for in vivo dosing studies
- High reported purity for reliable experimental results
- Supplied as a solid suitable for formulation and analytical work
- Available in multiple small research sizes for dose-ranging studies